ALLMedicine™ Percutaneous Liver Biopsy Center
Research & Reviews 315 results
https://doi.org/10.1210/clinem/dgaa892
The Journal of Clinical Endocrinology and Metabolism; Russo MF, Lembo E et. al.
Nov 28th, 2020 - Non-alcoholic steatohepatitis(NASH)is considered as the hepatic counterpart of the metabolic syndrome. To investigate the determinants of NASH reversal in patients undergoing biliopancreatic diversion(BPD)in a 5-year follow-up study. Prospective S...
https://doi.org/10.1007/s11695-020-05002-4 10.1016/j.jhep.2016.07.033 10.1016/j.mayocp.2015.06.013 10.1016/j.metabol.2015.10.032 10.23736/S0391-1977.16.02563-3 10.1016/j.metabol.2018.11.014 10.1007/s00464-016-5082-8 10.1016/j.soard.2017.09.005 10.3748/wjg.v20.i42.15532 10.2147/HMER.S245455 10.1016/j.ultrasmedbio.2010.07.005 10.1016/j.jhep.2007.07.006 10.4254/wjh.v7.i3.607 10.1016/j.jhep.2017.07.027 10.3748/wjg.v24.i28.3112 10.4103/0366-6999.149223 10.1016/j.soard.2017.07.032 10.5152/dir.2018.17525 10.1016/j.clnesp.2020.02.010 10.1007/s10620-017-4638-3 10.1007/s10620-016-4349-1 10.1016/j.jpeds.2016.03.021 10.1053/j.gastro.2019.01.042 10.1016/j.transproceed.2019.01.197 10.1007/s12072-018-9843-4 10.1007/s10620-012-2306-1 10.1016/j.clinre.2019.06.007 10.1111/jgh.13671 10.1007/s12664-014-0491-x 10.1007/s00261-017-1045-3 10.1111/liv.13260 10.1007/s10620-011-1659-1 10.1007/s11695-020-04513-4 10.1111/j.1365-2893.2011.01518.x 10.1007/s12664-019-00991-2 10.1002/hep.23312 10.3348/kjr.2004.5.1.11 10.1186/s12876-019-0961-9 10.1186/s13244-020-0839-y 10.1111/jgh.14150 10.1148/radiol.2016160685 10.1186/s12876-017-0617-6 10.1007/s12072-014-9573-1 10.1111/apt.12186 10.1016/j.ejrad.2011.10.029 10.1111/hepr.12649 10.1111/hepr.13508 10.1111/1751-2980.12868 10.1016/j.cld.2012.05.001 10.1007/s12072-013-9450-3 10.1016/j.cgh.2017.10.037 10.1371/journal.pone.0091987 10.1002/hep.24013 10.1111/j.1478-3231.2010.02331.x 10.5604/16652681.1222101 10.1002/hep.27844 10.1002/hep.28843 10.5604/01.3001.0012.3138 10.1007/s11901-018-0421-y 10.1111/j.1440-1746.2010.06510.x 10.1007/s00330-010-1820-9 10.1111/jvh.12296 10.1002/hep.24624 10.1007/s11695-014-1235-9 10.1016/j.soard.2019.10.025 10.1007/s11695-016-2054-y 10.1007/s11695-017-3012-z 10.1007/s11695-011-0559-y 10.1016/j.soard.2015.02.006 10.1002/hep.21178 10.1002/hep.21496 10.1016/s2468-1253(19)30383-8S
Obesity Surgery; Puthenpura MM, Patel V et. al.
Sep 27th, 2020 - Transient elastography (TE) is a non-invasive technology that demonstrates promise in assessing liver steatosis and fibrosis without the risks of traditional percutaneous liver biopsy. Many studies have examined its reliability in respect to liver...
https://doi.org/10.1097/MPG.0000000000002821
Journal of Pediatric Gastroenterology and Nutrition; Alomari MH, Kerr CL et. al.
Sep 22nd, 2020 - Following percutaneous liver biopsy performed at our institution on an outpatient basis, children traditionally were observed for 4 hours then discharged after verifying a stable hematocrit level. In June 2015, we adopted a quality improvement pro...
https://doi.org/10.1007/s00247-020-04783-1
Pediatric Radiology; Shapira-Zaltsberg G, Connolly B et. al.
Aug 13th, 2020 - Surveillance post image-guided percutaneous liver biopsy in children is variable. The aim of this study was to assess the value of 4-6-h post-procedure ultrasonography (US) in detecting post-liver-biopsy hemorrhage. This prospective study included...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599171
European Radiology; Fotiadis N, De Paepe KN et. al.
Jul 15th, 2020 - Percutaneous liver biopsy (PLB) poses specific challenges in oncological patients such as bleeding and tumour seeding. This study's aim was to compare a coaxial (C-PLB) and non-coaxial (NC-PLB) biopsy technique in terms of diagnostic yield, safety...
Clinicaltrials.gov 315 results
https://doi.org/10.1210/clinem/dgaa892
The Journal of Clinical Endocrinology and Metabolism; Russo MF, Lembo E et. al.
Nov 28th, 2020 - Non-alcoholic steatohepatitis(NASH)is considered as the hepatic counterpart of the metabolic syndrome. To investigate the determinants of NASH reversal in patients undergoing biliopancreatic diversion(BPD)in a 5-year follow-up study. Prospective S...
https://doi.org/10.1007/s11695-020-05002-4 10.1016/j.jhep.2016.07.033 10.1016/j.mayocp.2015.06.013 10.1016/j.metabol.2015.10.032 10.23736/S0391-1977.16.02563-3 10.1016/j.metabol.2018.11.014 10.1007/s00464-016-5082-8 10.1016/j.soard.2017.09.005 10.3748/wjg.v20.i42.15532 10.2147/HMER.S245455 10.1016/j.ultrasmedbio.2010.07.005 10.1016/j.jhep.2007.07.006 10.4254/wjh.v7.i3.607 10.1016/j.jhep.2017.07.027 10.3748/wjg.v24.i28.3112 10.4103/0366-6999.149223 10.1016/j.soard.2017.07.032 10.5152/dir.2018.17525 10.1016/j.clnesp.2020.02.010 10.1007/s10620-017-4638-3 10.1007/s10620-016-4349-1 10.1016/j.jpeds.2016.03.021 10.1053/j.gastro.2019.01.042 10.1016/j.transproceed.2019.01.197 10.1007/s12072-018-9843-4 10.1007/s10620-012-2306-1 10.1016/j.clinre.2019.06.007 10.1111/jgh.13671 10.1007/s12664-014-0491-x 10.1007/s00261-017-1045-3 10.1111/liv.13260 10.1007/s10620-011-1659-1 10.1007/s11695-020-04513-4 10.1111/j.1365-2893.2011.01518.x 10.1007/s12664-019-00991-2 10.1002/hep.23312 10.3348/kjr.2004.5.1.11 10.1186/s12876-019-0961-9 10.1186/s13244-020-0839-y 10.1111/jgh.14150 10.1148/radiol.2016160685 10.1186/s12876-017-0617-6 10.1007/s12072-014-9573-1 10.1111/apt.12186 10.1016/j.ejrad.2011.10.029 10.1111/hepr.12649 10.1111/hepr.13508 10.1111/1751-2980.12868 10.1016/j.cld.2012.05.001 10.1007/s12072-013-9450-3 10.1016/j.cgh.2017.10.037 10.1371/journal.pone.0091987 10.1002/hep.24013 10.1111/j.1478-3231.2010.02331.x 10.5604/16652681.1222101 10.1002/hep.27844 10.1002/hep.28843 10.5604/01.3001.0012.3138 10.1007/s11901-018-0421-y 10.1111/j.1440-1746.2010.06510.x 10.1007/s00330-010-1820-9 10.1111/jvh.12296 10.1002/hep.24624 10.1007/s11695-014-1235-9 10.1016/j.soard.2019.10.025 10.1007/s11695-016-2054-y 10.1007/s11695-017-3012-z 10.1007/s11695-011-0559-y 10.1016/j.soard.2015.02.006 10.1002/hep.21178 10.1002/hep.21496 10.1016/s2468-1253(19)30383-8S
Obesity Surgery; Puthenpura MM, Patel V et. al.
Sep 27th, 2020 - Transient elastography (TE) is a non-invasive technology that demonstrates promise in assessing liver steatosis and fibrosis without the risks of traditional percutaneous liver biopsy. Many studies have examined its reliability in respect to liver...
https://doi.org/10.1097/MPG.0000000000002821
Journal of Pediatric Gastroenterology and Nutrition; Alomari MH, Kerr CL et. al.
Sep 22nd, 2020 - Following percutaneous liver biopsy performed at our institution on an outpatient basis, children traditionally were observed for 4 hours then discharged after verifying a stable hematocrit level. In June 2015, we adopted a quality improvement pro...
https://doi.org/10.1007/s00247-020-04783-1
Pediatric Radiology; Shapira-Zaltsberg G, Connolly B et. al.
Aug 13th, 2020 - Surveillance post image-guided percutaneous liver biopsy in children is variable. The aim of this study was to assess the value of 4-6-h post-procedure ultrasonography (US) in detecting post-liver-biopsy hemorrhage. This prospective study included...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599171
European Radiology; Fotiadis N, De Paepe KN et. al.
Jul 15th, 2020 - Percutaneous liver biopsy (PLB) poses specific challenges in oncological patients such as bleeding and tumour seeding. This study's aim was to compare a coaxial (C-PLB) and non-coaxial (NC-PLB) biopsy technique in terms of diagnostic yield, safety...
